- Latest week
- 10 Jul 2026
- Close
- 49.480000
- Fair value
- 80.911965
- Next-week expectancy
- Undecided 46.20%
NVO Chart Pack
Novo Nordisk A/S
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, NVO rose 20.18%, moving from 41.17 to 49.48. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -8.06 and has improved across the 12-week window. Market Dynamics is 0.79 on the latest week. Next-week expectancy is undecided at 46.20% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 49.48
- 12-Week Change
- 20.18%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 46.20%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- -8.06
- Market Dynamics
- 0.79
Weekly Price
Price Action
Smart Money
Market Dynamics
Earnings vs Price
Earnings vs Price
Weekly price against rolling TTM EPS, both indexed to 100 from the first visible week.
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 49.48
- 12-Week Change
- 20.18%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 46.20%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- -8.06
- Market Dynamics
- 0.79
Over the latest 12 completed weeks ending 2026-07-10, NVO rose 20.18%, moving from 41.17 to 49.48. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -8.06 and has improved across the 12-week window. Market Dynamics is 0.79 on the latest week. Next-week expectancy is undecided at 46.20% based on similar historical setup states.
Industry Peers
United States equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| SCLX Scilex Holding Company | NASDAQ | 10 Jul 2026 | 7.68 | 10.43 | 7.01 | 9.48 | 23.44% |
| GRFS Grifols SA ADR | NASDAQ | 10 Jul 2026 | 7.14 | 7.32 | 7.05 | 7.27 | 1.82% |
| SNY Sanofi ADR | NASDAQ | 10 Jul 2026 | 43.37 | 44.11 | 42.43 | 43.50 | 0.30% |
| PFE Pfizer Inc | NYSE | 10 Jul 2026 | 24.16 | 24.41 | 23.62 | 24.17 | 0.06% |
| OGN Organon & Co | NYSE | 10 Jul 2026 | 13.55 | 13.58 | 13.46 | 13.52 | -0.22% |
| BMY Bristol-Myers Squibb Company | NYSE | 10 Jul 2026 | 57.74 | 58.49 | 56.49 | 57.58 | -0.28% |
| JNJ Johnson & Johnson | NYSE | 10 Jul 2026 | 260.23 | 269.43 | 255.52 | 256.98 | -1.25% |
| LLY Eli Lilly and Company | NYSE | 10 Jul 2026 | 1208.00 | 1249.45 | 1178.32 | 1188.58 | -1.61% |
| MIRA MIRA Pharmaceuticals, Inc. Common Stock | NASDAQ | 10 Jul 2026 | 0.94 | 0.99 | 0.90 | 0.92 | -1.65% |
| GSK GlaxoSmithKline PLC ADR | NYSE | 10 Jul 2026 | 53.80 | 54.29 | 52.30 | 52.78 | -1.90% |
| NVS Novartis AG ADR | NYSE | 10 Jul 2026 | 157.32 | 157.93 | 153.63 | 154.05 | -2.08% |
| AMGN Amgen Inc | NASDAQ | 10 Jul 2026 | 371.70 | 375.25 | 359.47 | 363.39 | -2.24% |
| GILD Gilead Sciences Inc | NASDAQ | 10 Jul 2026 | 132.88 | 137.70 | 127.88 | 129.83 | -2.30% |
| MRK Merck & Company Inc | NYSE | 10 Jul 2026 | 129.31 | 130.00 | 122.90 | 123.54 | -4.46% |
| ABBV AbbVie Inc | NYSE | 10 Jul 2026 | 259.92 | 260.92 | 245.05 | 248.08 | -4.56% |
| MDCX Medicus Pharma Ltd. Common Stock | NASDAQ | 10 Jul 2026 | 0.43 | 0.47 | 0.40 | 0.41 | -4.77% |